Aventis Files Fresh Patent Suit Against Mylan Over Generic Allegra
Aventis' patents for the lucrative allergy drug Allegra spawned new litigation last week against Mylan Pharmaceuticals, just as new plans were announced by rivals Barr and Teva to cooperate in manufacturing...To view the full article, register now.
Already a subscriber? Click here to view full article